<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02956265</url>
  </required_header>
  <id_info>
    <org_study_id>2016-05-CHRMT</org_study_id>
    <nct_id>NCT02956265</nct_id>
  </id_info>
  <brief_title>Optical Spectroscopy for Skin Carcinomas' Surgical Management</brief_title>
  <acronym>SPETROLIVE</acronym>
  <official_title>Assessment of Optical Spectroscopy's Diagnosis Accuracy When Non-invasively and Automatically Classifying Skin Lesions in One of the Following Histological Classes: Healthy, Actinic Keratosis, in Situ Carcinoma and Invasive Carcinoma.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional Metz-Thionville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Lorraine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Régional Metz-Thionville</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Actinic keratosis are of utmost medical and economical interest because of their high&#xD;
      prevalence (20 % of 60 year-old people and older in the Northern hemisphere) and their&#xD;
      important cosmetic impact as such actinic keratosis mostly appear on photo-exposed skin&#xD;
      sites. The surgeon in charge of such lesions' removal (i) some actinic keratosis adjoining&#xD;
      carcinoma to be resected therefore causing the problem of functional areas damaging (eyelids,&#xD;
      lips, etc.) or (ii) numerous actinic keratosis localized away from carcinoma&#xD;
      (photo-carcinogenesis field) faces the issue of clinical evaluation of such lesions: which&#xD;
      ones will spontaneously regress (it is supposed to be the case for 20 % of such&#xD;
      lesions);which ones will remain and which ones will develop into invasive carcinomas ?&#xD;
&#xD;
      A non-invasive, non-traumatic, automated and real-time help for the clinical diagnosis&#xD;
      orientation of such skin lesions could help improving diagnosis accuracy of the medical&#xD;
      practitioner's visual inspection:&#xD;
&#xD;
        -  In terms of sensitivity in order to potentially decrease the number of actinic keratosis&#xD;
           evolving towards invasive carcinoma,&#xD;
&#xD;
        -  In terms of specificity in order to potentially decrease useless resections and reduce&#xD;
           resection margins and therefore reduce scars surface.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Actual">March 25, 2021</completion_date>
  <primary_completion_date type="Actual">March 25, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Optical spectroscopy's diagnostic validity for the 4 histological classes discrimination</measure>
    <time_frame>day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Statistical significance degree of the discrimination by molecular profiling (transcriptomic characterization) between in situ carcinoma (ISC) and invasive carcinoma (InvC).</measure>
    <time_frame>day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Statistical significance degree of the discrimination by molecular profiling (transcriptomic characterization) between 2 classes of actinic keratosis (AK) of clinical relevance: AK characterized by a &quot;low&quot; versus a &quot;high&quot; invasiveness risk</measure>
    <time_frame>day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Sensitivity and specificity of optical spectroscopy for discriminating the é molecular classes of actinic keratosis: AK characterized by a &quot;low&quot; versus a &quot;high&quot; invasiveness risk.</measure>
    <time_frame>day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">142</enrollment>
  <condition>Carcinomatous or Polymorphous Skin Lesions</condition>
  <arm_group>
    <arm_group_label>Patients - Suffering from carcinomatous or polymorphous skin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bimodal optical spectroscopy</intervention_name>
    <description>an optical fiber will be put in gentle contact with the patient's skin in order to acquire optical spectra</description>
    <arm_group_label>Patients - Suffering from carcinomatous or polymorphous skin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults, and&#xD;
&#xD;
          -  Autonomous: enjoying full citizenship rights and full mental abilities, and&#xD;
&#xD;
          -  Affiliated to a social security system, and&#xD;
&#xD;
          -  Suffering from carcinomatous or polymorphous skin lesions that can be fully managed in&#xD;
             an outpatient (ambulatory) surgery procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Carcinomatous or polymorphous skin lesions that require day admission, or&#xD;
&#xD;
          -  Carcinomatous or polymorphous skin lesions for which resection margins are uncertain,&#xD;
             or&#xD;
&#xD;
          -  Naevomatous skin lesions and related skin pathologies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grégoire Khairallah</last_name>
    <role>Principal Investigator</role>
    <affiliation>g.khairallah@chr-metz-thionville.fr</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHR Metz Thionville</name>
      <address>
        <city>Metz</city>
        <zip>57085</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>November 3, 2016</study_first_submitted>
  <study_first_submitted_qc>November 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2016</study_first_posted>
  <last_update_submitted>June 14, 2021</last_update_submitted>
  <last_update_submitted_qc>June 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

